Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.56B |
| 2 |
Eli Lilly
LLY
|
+$1.91B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$919M |
| 4 |
Cigna
CI
|
+$806M |
| 5 |
Netflix
NFLX
|
+$669M |
Top Sells
| 1 |
Amgen
AMGN
|
+$1.39B |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$1.12B |
| 3 |
Stryker
SYK
|
+$1.12B |
| 4 |
Comcast
CMCSA
|
+$1.09B |
| 5 |
Becton Dickinson
BDX
|
+$1B |
Sector Composition
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
J&J Snack Foods
JJSF
$2.02B
| $13.9M | ﹤0.01% |
114,936
+114,653
| +40,513% | +$13.9M |
|
1527
Apellis Pharmaceuticals
APLS
$3.14B
| $13.9M | ﹤0.01% |
518,534
-20,900
| -4% | -$560K |
|
|
GMLP
1528
DELISTED
Golar LNG Partners LP
GMLP
| $13.9M | ﹤0.01% |
4,126,579
-2,850,248
| -41% | -$9.58M |
|
|
LX
1529
LexinFintech Holdings
LX
$961M
| $13.8M | ﹤0.01% |
1,558,551
-1,586
| -0.1% | -$14.1K |
|
1530
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $13.8M | ﹤0.01% |
551,120
+255,377
| +86% | +$6.37M |
|
1531
Genesco
GCO
$358M
| $13.8M | ﹤0.01% |
1,031,068
+475,284
| +86% | +$6.34M |
|
1532
KalVista Pharmaceuticals
KALV
$708M
| $13.7M | ﹤0.01% |
1,790,791
+123,813
| +7% | +$947K |
|
1533
Prudential
PUK
$35.5B
| $13.7M | ﹤0.01% |
569,104
+404,391
| +246% | +$9.72M |
|
|
CVLY
1534
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $13.7M | ﹤0.01% |
849,263
+2,173
| +0.3% | +$35K |
|
1535
First Majestic Silver
AG
$5.15B
| $13.6M | ﹤0.01% |
2,200,000
+600,000
| +38% | +$3.72M |
|
1536
Teleflex
TFX
$5.76B
| $13.6M | ﹤0.01% |
46,499
-69,077
| -60% | -$20.2M |
|
1537
Pan American Silver
PAAS
$15.5B
| $13.6M | ﹤0.01% |
950,004
-2,485,372
| -72% | -$35.6M |
|
1538
NMI Holdings
NMIH
$3.08B
| $13.6M | ﹤0.01% |
1,171,828
-124,342
| -10% | -$1.44M |
|
1539
Repay Holdings
RPAY
$507M
| $13.6M | ﹤0.01% |
945,860
-164,400
| -15% | -$2.36M |
|
1540
Nucor
NUE
$32.4B
| $13.6M | ﹤0.01% |
376,521
+5,037
| +1% | +$181K |
|
1541
BioXcel Therapeutics
BTAI
$49.8M
| $13.5M | ﹤0.01% |
37,843
-19,069
| -34% | -$6.82M |
|
1542
Bridgewater Bancshares
BWB
$457M
| $13.4M | ﹤0.01% |
1,377,800
-128,171
| -9% | -$1.25M |
|
1543
Takeda Pharmaceutical
TAK
$47.7B
| $13.4M | ﹤0.01% |
883,794
+328,184
| +59% | +$4.98M |
|
1544
Builders FirstSource
BLDR
$15.8B
| $13.4M | ﹤0.01% |
1,092,944
-137,238
| -11% | -$1.68M |
|
1545
American Woodmark
AMWD
$995M
| $13.3M | ﹤0.01% |
292,454
-19,663
| -6% | -$896K |
|
|
DTP
1546
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $13.3M | ﹤0.01% |
333,000
+198,000
| +147% | +$7.91M |
|
1547
Preferred Bank
PFBC
$1.16B
| $13.3M | ﹤0.01% |
392,675
+257,008
| +189% | +$8.69M |
|
1548
ManpowerGroup
MAN
$1.78B
| $13.3M | ﹤0.01% |
250,559
-249,061
| -50% | -$13.2M |
|
|
DRNA
1549
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $13.3M | ﹤0.01% |
722,512
| – | – |
|
1550
Stoneridge
SRI
$228M
| $13.3M | ﹤0.01% |
791,500
+121,260
| +18% | +$2.03M |
|